DERM Earnings
Latest Revenue17.8M
Latest Net Income-312000
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | -$0.01 | 17.8M | -312000 | +18.9% | +93.8% |
| Q1 2026 | -$0.08 | 16.0M | -2230000 | +21.5% | +55.6% |
| Q4 2025 | -$0.05 | 16.1M | -1247000 | +27.3% | -171.4% |
| Q3 2025 | -$0.09 | 17.0M | -2315000 | +16.4% | +25.0% |
| Q2 2025 | -$0.16 | 15.0M | -3796000 | +1.0% | +5.9% |
| Q1 2025 | -$0.18 | 13.1M | -4073000 | +0.8% | +66.0% |
| Q4 2024 | $0.07 | 12.6M | 1.5M | -17.3% | +163.6% |
| Q3 2024 | -$0.12 | 14.6M | -2390000 | -57.6% | -113.2% |
| Q2 2024 | -$0.17 | 14.9M | -3361000 | — | — |
| Q1 2024 | -$0.53 | 13.0M | -10442000 | — | — |
| Q4 2023 | -$0.11 | 15.3M | -2143000 | — | — |
| Q3 2023 | $0.91 | 34.5M | 16.8M | — | — |
Journey Medical (DERM) — Earnings